NCIC Clinical Trials Group

Brain Gastro-Intestinal Gynecologic Hematologic Lung Sarcoma
Breast Genito-Urinary Head & Neck IND Melanoma Symptom Control

Current Trials

Spring Meeting 2009 Trial Reports

Radioisotope Shortages and NCIC CTG Trial Guidelines

Please select a disease site then trial for information such as: Downloadable: Protocols / Consents / Forms, Administrative Updates / Amendments, Letters / Memos, Trial Summaries, Spring Meeting Cover Page, E-mail Contacts
 

 

Accrual: Phase III - Closed Studies

Accrual: IND Trials - Closed Studies


Safety Information

General Information



Safety Reports Permanent Trial Closure
Letter of introduction / instruction to Web Based Safety Reports Required Ethics Education
Memorandum to Centres: Serious Adverse Event Reporting Change / Clarification GCP Training
Memorandum to Centres: Safety Reports That Do Not Require Submission to REB's - 2007 Mar 01 Revised RECIST guideline (version 1.1)
AdEERS Reporting [trials using NCI US investigational agents] Guide to Completing a Participants List
Data Safety Monitoring Committee (DSMC) - Summary Reports Participants List Change Form
  Guidance for Investigators
  Generic Activation Forms
  Generic Form 5M - CDN
  Generic Form 5M - US

Use this to link back to CTG home only

If you have any questions, comments or suggestions, please contact our